562.0 est. views 3.70%
health10h ago

FDA to request Sarepta Therapeutics halt shipments of Duchenne gene therapy

https://www.statnews.com/2025/07/18/sarepta-therapeutics-duchenne-elevydis-fda-shipments-request/https://www.cnbc.com/2025/07/18/sarepta-stock-falls-on-fda-gene-therapy-elevidys-comment.htmlhttps://www.clinicaltrialsarena.com/news/third-gene-therapy-death-sends-sarepta-shares-lower/
Statnews.com and 2 more
FDA to request Sarepta Therapeutics halt shipments of Duchenne gene therapy Open in Statnews.com
Vote 2
0

References

Sarepta shares plunge 40% as future of its gene therapy appears at risk

Sarepta shares plunge 40% as future of its gene therapy appears at risk

Sarepta share price drops again after third gene therapy death

Sarepta share price drops again after third gene therapy death

Related Topics

0 Comments

Be the first to comment

Add your thoughts and get the conversation going.

Top 563 Internet News Today

Explore Your Interests

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access
Personalized Feed
Full Experience
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.